Targeting mucin hypersecretion in COVID-19 therapy

Detalles Bibliográficos
Autores principales: Prasher, Parteek, Sharma, Mousmee
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Newlands Press Ltd 2022
Materias:
Commentary
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8939459/
https://www.ncbi.nlm.nih.gov/pubmed/35315705
http://dx.doi.org/10.4155/fmc-2021-0111
_version_ 1784672732122710016
author Prasher, Parteek
Sharma, Mousmee
author_facet Prasher, Parteek
Sharma, Mousmee
author_sort Prasher, Parteek
collection PubMed
description
format Online
Article
Text
id pubmed-8939459
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Newlands Press Ltd
record_format MEDLINE/PubMed
spelling pubmed-89394592022-03-29 Targeting mucin hypersecretion in COVID-19 therapy Prasher, Parteek Sharma, Mousmee Future Med Chem Commentary Newlands Press Ltd 2022-03-22 2022-03 /pmc/articles/PMC8939459/ /pubmed/35315705 http://dx.doi.org/10.4155/fmc-2021-0111 Text en © 2022 Newlands Press https://creativecommons.org/licenses/by/4.0/This work is licensed under the Creative Commons Attribution 4.0 License (https://creativecommons.org/licenses/by/4.0/)
spellingShingle Commentary
Prasher, Parteek
Sharma, Mousmee
Targeting mucin hypersecretion in COVID-19 therapy
title Targeting mucin hypersecretion in COVID-19 therapy
title_full Targeting mucin hypersecretion in COVID-19 therapy
title_fullStr Targeting mucin hypersecretion in COVID-19 therapy
title_full_unstemmed Targeting mucin hypersecretion in COVID-19 therapy
title_short Targeting mucin hypersecretion in COVID-19 therapy
title_sort targeting mucin hypersecretion in covid-19 therapy
topic Commentary
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8939459/
https://www.ncbi.nlm.nih.gov/pubmed/35315705
http://dx.doi.org/10.4155/fmc-2021-0111
work_keys_str_mv AT prasherparteek targetingmucinhypersecretionincovid19therapy
AT sharmamousmee targetingmucinhypersecretionincovid19therapy

Ejemplares similares